Literature DB >> 23763758

The clinical importance of fungal biofilms.

Gordon Ramage1, Craig Williams.   

Abstract

Fungal biofilms have become an increasingly important clinical problem. The widespread use of antibiotics, frequent use of indwelling medical devices, and a trend toward increased patient immunosuppression have resulted in a creation of opportunity for clinically important yeasts and molds to form biofilms. This review will discuss the diversity and importance of fungal biofilms in the context of clinical medicine, provide novel insights into the clinical management of fungal biofilm infection, present evidence why these structures are recalcitrant to antifungal therapy, and discuss how our knowledge and understanding may lead to novel therapeutic intervention.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23763758     DOI: 10.1016/B978-0-12-407673-0.00002-3

Source DB:  PubMed          Journal:  Adv Appl Microbiol        ISSN: 0065-2164            Impact factor:   5.086


  21 in total

1.  Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.

Authors:  Kaat De Cremer; Ellen Lanckacker; Tanne L Cools; Marijke Bax; Katrijn De Brucker; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Relationship between biofilms and clinical features in patients with sinus fungal ball.

Authors:  Xiao Wang; Dong Dong; Jingliang Cheng; Xinjuan Fan; Yulin Zhao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

3.  Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation.

Authors:  Angélica de L Rodríguez López; Myung-Ryul Lee; Nathan B Wang; Kaitlin K Dunn; Hiram Sanchez; Namrata Raman; David R Andes; David M Lynn; Sean P Palecek
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

4.  N-trimethylchitosan/alginate layer-by-layer self assembly coatings act as "fungal repellents" to prevent biofilm formation on healthcare materials.

Authors:  Fuguang Jiang; Chih-Ko Yeh; Jianchuan Wen; Yuyu Sun
Journal:  Adv Healthc Mater       Date:  2014-10-08       Impact factor: 9.933

Review 5.  Cryptococcus spp. and Cryptococcosis: focusing on the infection in Brazil.

Authors:  Fabíolla Nacimento do Carmo; Juliana de Camargo Fenley; Maíra Terra Garcia; Rodnei Dennis Rossoni; Juliana Campos Junqueira; Patrícia Pimentel de Barros; Liliana Scorzoni
Journal:  Braz J Microbiol       Date:  2022-04-29       Impact factor: 2.214

6.  Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.

Authors:  Jana Tits; Freya Cools; Kaat De Cremer; Katrijn De Brucker; Judith Berman; Kristof Verbruggen; Bert Gevaert; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

7.  Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation.

Authors:  Ranjith Rajendran; Leighann Sherry; David F Lappin; Chris J Nile; Karen Smith; Craig Williams; Carol A Munro; Gordon Ramage
Journal:  BMC Microbiol       Date:  2014-12-05       Impact factor: 3.605

8.  Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase.

Authors:  Rasmus Bojsen; Birgitte Regenberg; Anders Folkesson
Journal:  BMC Microbiol       Date:  2014-12-04       Impact factor: 3.605

9.  Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model.

Authors:  Tatiane Benaducci; Janaina de C O Sardi; Natalia M S Lourencetti; Liliana Scorzoni; Fernanda P Gullo; Suélen A Rossi; Jaqueline B Derissi; Márcia C de Azevedo Prata; Ana M Fusco-Almeida; Maria J S Mendes-Giannini
Journal:  Front Microbiol       Date:  2016-03-09       Impact factor: 5.640

10.  Proteomic profile of Cryptococcus neoformans biofilm reveals changes in metabolic processes.

Authors:  Lucélia Santi; Walter O Beys-da-Silva; Markus Berger; Diego Calzolari; Jorge A Guimarães; James J Moresco; John R Yates
Journal:  J Proteome Res       Date:  2014-01-27       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.